MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-401

  1. 30,316 Posts.
    lightbulb Created with Sketch. 1836
    Firstly it's not your job to worry about investors as you claim to do, but I strongly doubt you truly mean it. Also the I like you but.. is a falsely disarming intro to a misleading argument.

    MSB's ARDS technology is already proven, and approved in Japan in the aGVHD space.

    You're raising the stakes as if all the technology is entirely unproven.

    It's proven, OK?

    It comes down to delivery and design.

    What MUST happen is a less-biased FDA.

    But I do understand that some brokers have had the heads-up about this for a long time and played it hard on what they know about pharmaceutical drug competitors and the obvious corruption of a decision maker in the FDA who has a clear interest in blocking MSB and backing this own company.

    This is WRONG. But since when has the USA been running without bias. It's been elevated to an art form since Trump.

    I can read the signs well. Many are too triggered emotionally to do that. But you understand that, it's your stock-in-trade.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.